Integrated BioPharma, Inc. (INBP)
OTCMKTS
· Delayed Price · Currency is USD
0.300
+0.040 (15.38%)
Feb 14, 2025, 4:00 PM EST
Integrated BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | 0.93 | 0.11 | -0.03 | 3.84 | 8.01 | 4.11 | Upgrade
|
| Depreciation & Amortization | 1.26 | 1.22 | 1.15 | 0.83 | 0.83 | 0.77 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | -0 | -0.02 | -0.01 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.03 | - | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | 0.01 | 0.06 | -0 | -0.18 | Upgrade
|
| Stock-Based Compensation | 0.22 | 0.25 | 0.32 | 0.37 | 0.23 | 0.06 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.04 | -0.04 | 0 | - | 0.03 | 0.02 | Upgrade
|
| Other Operating Activities | 0.45 | 0.14 | 0.08 | -1.5 | -2.98 | -1.33 | Upgrade
|
| Change in Accounts Receivable | -0.46 | -0.12 | 0.37 | 0.88 | -0.29 | -1.08 | Upgrade
|
| Change in Inventory | 1.08 | -0.98 | 0.79 | 0.64 | -1.59 | -1.28 | Upgrade
|
| Change in Accounts Payable | -0.5 | 0.24 | -0.92 | -0.22 | -0.94 | 0.49 | Upgrade
|
| Change in Other Net Operating Assets | -0.66 | 0.12 | -0.55 | -0.78 | -0.22 | -0.23 | Upgrade
|
| Operating Cash Flow | 2.32 | 0.94 | 1.23 | 4.09 | 3.05 | 1.34 | Upgrade
|
| Operating Cash Flow Growth | - | -23.46% | -69.89% | 34.13% | 127.78% | 308.23% | Upgrade
|
| Capital Expenditures | -0.58 | -0.55 | -0.12 | -0.49 | -0.3 | -0.21 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0 | 0.02 | - | 0 | Upgrade
|
| Investment in Securities | - | - | 0 | - | 0.1 | 0.1 | Upgrade
|
| Investing Cash Flow | -0.58 | -0.55 | -0.11 | -0.47 | -0.2 | -0.11 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 57.66 | 47.21 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 1.64 | Upgrade
|
| Total Debt Issued | - | - | - | - | 57.66 | 48.85 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.1 | -2.07 | -59.54 | -49 | Upgrade
|
| Long-Term Debt Repaid | - | -0.04 | -0.04 | -1.47 | -1.19 | -1.16 | Upgrade
|
| Total Debt Repaid | -0.03 | -0.04 | -0.14 | -3.54 | -60.73 | -50.16 | Upgrade
|
| Net Debt Issued (Repaid) | -0.03 | -0.04 | -0.14 | -3.54 | -3.07 | -1.31 | Upgrade
|
| Issuance of Common Stock | 0.02 | 0.01 | - | 0.03 | 0.02 | 0.01 | Upgrade
|
| Financing Cash Flow | -0.01 | -0.03 | -0.14 | -3.51 | -3.04 | -1.3 | Upgrade
|
| Net Cash Flow | 1.73 | 0.36 | 0.99 | 0.12 | -0.19 | -0.07 | Upgrade
|
| Free Cash Flow | 1.74 | 0.39 | 1.12 | 3.61 | 2.76 | 1.13 | Upgrade
|
| Free Cash Flow Growth | - | -65.05% | -69.04% | 30.85% | 144.89% | - | Upgrade
|
| Free Cash Flow Margin | 3.34% | 0.78% | 2.20% | 6.41% | 4.33% | 2.13% | Upgrade
|
| Free Cash Flow Per Share | 0.06 | 0.01 | 0.04 | 0.11 | 0.09 | 0.04 | Upgrade
|
| Cash Interest Paid | 0.04 | 0.04 | 0.04 | 0.11 | 0.2 | 0.37 | Upgrade
|
| Cash Income Tax Paid | 0.1 | 0.04 | - | 0.47 | 0.56 | 0.38 | Upgrade
|
| Levered Free Cash Flow | 2.17 | 1.21 | 1.93 | 3.3 | 1.79 | 0.74 | Upgrade
|
| Unlevered Free Cash Flow | 2.17 | 1.21 | 1.94 | 3.38 | 1.95 | 0.99 | Upgrade
|
| Change in Net Working Capital | -0.37 | -0.13 | -0.51 | -0.95 | 2.43 | 1.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.